Skip to main content
. 2023 Nov 20;10:1256997. doi: 10.3389/fvets.2023.1256997

Table 3.

Resistance genes identified in MH isolated from study animals.

TxGroup (Isolates) Isolates with ARGs (Multiple ARGs) Amin (a3”, a6) B-lac (bO, bR) MLS (me, mm) Phen Tet (tH, tR) Total ARGs
META (139 total) 102 (75) 43 (1, 42) 77 (73, 34) 73 (73, 73) 41 100 (100, 51) 491
Arrival (39) 13 (8) 5 (0, 5) 9 (6, 9) 6 (6, 6) 4 12 (12, 4) 52
WK3 (77) 75 (55*) 29 (0, 29) 55 (55, 23) 55 (55, 55) 29 75 (75, 35) 360
WK10 (23) 14 (12) 9 (1, 8) 13 (12, 3) 12 (12, 12) 8 13 (13, 10) 79
NO META (108 total) 59 (26) 17 (0, 17) 28 (25, 25) 26 (25, 26) 17 47 (47, 13) 196
Arrival (33) 11 (9) 7 (0, 7) 10 (9, 9) 9 (9, 9) 7 10 (10, 4) 65
WK3 (62) 31 (13) 7 (0, 7) 14 (12, 13) 13 (12, 13) 7 30 (30, 6) 100
WK10 (13) 7 (4) 3 (0, 3) 4 (4, 3) 4 (4, 4) 3 7 (7, 3) 31
Grand total (246) 151 (101) 60 (1, 59) 105 (98, 59) 99 (98, 99) 58 147 (147, 62) 687

*Significant difference in isolation of MDR MH compared to previous time point (McNemar’s χ2 test, p < 0.0001). TxGroup, treatment group; META, tulathromycin metaphylaxis; NO META, no tulathromycin metaphylaxis; ARG, antimicrobial resistance gene; WK3, week 3; WK10, week 10; Amin, aminoglycoside; B-lac, beta-lactams; MLS, macrolide-lincosamide-streptogramins; Phen, phenicols; Tet, tetracyclines; a3”,aph(3″); a6’, aph(6′); bo, blaOXA; bR, blaROB; me, erm(42); mm, msr(E); tH, tetH;tR, tetR.